Table 2.
Baseline Symptom Severity and Current and Lifetime Mental Health Service Use by Year and Overall for Patients Who Started the Wellbeing Course.
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | Total | Significance | |
|---|---|---|---|---|---|---|---|---|---|
| Baseline symptom scores | |||||||||
| Mean PHQ-9 (SD) | 11.86 (5.05) | 12.59 (5.67) | 12.05 (5.66) | 11.79 (5.95) | 12.34 (5.92) | 12.02 (5.79) | 11.91 (5.62) | 12.05 (5.76) | F (6,3995) = 1.03, P = 0.40 |
| Mean GAD-7 (SD) | 12.07 (5.66) | 12.07 (5.10) | 11.13 (5.27) | 11.81 (5.20) | 12.31 (5.00) | 12.05 (5.14) | 11.62 (4.95) | 11.85 (5.09) | F (6,3995) = 3.02, P = 0.006 |
| Mean K10 (SD) | 26.36 (6.84) | 27.82 (7.45) | 27.14 (7.30) | 27.52 (7.34) | 28.46 (7.80) | 28.20 (7.60) | 27.64 (7.58) | 27.84 (7.55) | F (6, 3995) = 2.14, P = 0.04 |
| Mean SDS (SD) | 18.11 (8.10) | 17.37 (8.00) | 17.58 (7.72) | 17.11 (7.67) | 17.01 (7.65) | 17.02 (7.87) | 16.89 (7.92) | 17.09 (7.81) | F (6, 3995) = 0.56, P = 0.76 |
| Mean PDSS-SR (SD) | 9.39 (8.16) | 7.22 (6.22) | 7.41 (6.21) | 7.36 (6.12) | 7.57 (5.96) | 7.53 (5.92) | 7.14 (5.93) | 7.38 (6.03) | F (6,3995) = 1.07, P = 0.38 |
| Mean SPS/SIAS-6 (SD) | 12.18 (9.78) | 13.19 (10.39) | 14.23 (10.24) | 14.70 (10.37) | 15.01 (10.84) | 15.06 (11.29) | 14.91 (10.69) | 14.71 (10.73) | F (6,3995) = 1.61, P = 0.14 |
| Symptoms in the clinical range | |||||||||
| Depression or anxiety | 85.7% (24/28) | 84.0% (231/275) | 83,3% (339/407) | 81.6% (466/571) | 84.6% (605/715) | 84.4% (685/812) | 83.8% (1,002/1,195) | 83.7% (3,352/4,003) | χ2 (1, N = 4,003) = 0.26, P = 0.61 |
| Mental health service use (last 3 months) | |||||||||
| Receiving other mental health treatment | 32.1% (9/28) | 49.6% (134/270) | 47.2% (191/405) | 40.8% (233/571) | 43.0% (307/714) | 48.9% (397/812) | 49.2% (587/1,194) | 46.5% (1,858/3,994) | χ2 (1, N = 3,994) = 3.90, P = 0.05 |
| On wait-list for other services | — | — | 8.6% (16/187) | 9.6% (55/571) | 14.4% (103/714) | 14.2% (115/812) | 10.5% (125/1,194) | 11.9% (414/3,478) | χ2 (1, N = 3,532) = 0.16, P = 0.69 |
| Psychotropic medication | 42.9% (12/28) | 62.4% (171/274) | 60.4% (246/407) | 57.3% (327/571) | 56.2% (401/713) | 55.6% (451/811) | 56.9% (682/1,194) | 57.3% (2,292/3,999) | χ2 (1, N = 3,999) = 1.72, P = 0.19 |
| Mental health service use (lifetime) | |||||||||
| Family doctor/walk-in clinic | — | — | — | — | 88.6% (109/123) | 84.7% (688/812) | 86.9% (1,037/1,194) | 86.1% (1,834/2,129) | χ2 (1, N = 2,129) = 0.31, P = 0.58 |
| Psychiatrist | — | — | — | — | 30.9% (38/123) | 30.4% (247/812) | 32.5% (388/1,194) | 31.61% (673/2,129) | χ2 (1, N = 2,129) = 0.78, P = 0.38 |
Note. PHQ-9 = Patient Health Questionnaire 9-item; GAD-7 = Generalized Anxiety Disorder Questionnaire 7-item; K10 = Kessler Distress Scale; SDS = Sheehan Disability Scale; PDSS-SR = Panic Disorder Severity Scale Self-Report; SIAS-6/SPS-6 = Social Interaction Anxiety Scale and Social Phobia Scale (SIAS-6/SPS-6). Bonferroni correction P < 0.004.